Targeting the MDSCs of Tumors In Situ With Inhibitors of the MAPK Signaling Pathway to Promote Tumor Regression
Jiayun Yu(Sichuan University), Bin Shao(Sichuan University), Xiawei Wei(Sichuan University), Weimin Lin(Nanjing Agricultural University), Zongliang Zhang(Sichuan University), Hanwen Li(Yangzhou University)
Cited by 19
Related Papers
Targeting PI3K in cancer: mechanisms and advances in clinical trials
|Molecular Cancer|2019|1.6k
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
|Signal Transduction and Targeted Therapy|2019|1.1k
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
|Journal of Hematology & Oncology|2022|964
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
|Nature|2020|845
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
|Journal of Hematology & Oncology|2022|687